PMHNP Practice Authority in Oregon: Independence, Physician Agreements and Schedule II

AANP's May 2026 map puts Oregon in its full practice tier.

The label is AANP's advocacy classification; the legal fact behind it is statutory: ORS 678.390(1) authorizes the board to let a nurse practitioner write prescriptions including controlled substances in schedules II through V, and the board's scope rule describes the nurse practitioner as independently responsible and accountable for the continuous and comprehensive management of a broad range of health care (OAR 851-055-0020(5)).

The statute's own condition on what gets prescribed is scope: ORS 678.375(4) requires the drugs to be included within the NP's scope of practice as defined by board rules.

Prescribing runs on the nursing board's own authority, with no medical board in the chain.

For a PMHNP weighing a job offer, the independence is the licence-plus-board-authorization structure itself, not a phase that expires.

The sources read record no hours or years threshold before an Oregon nurse practitioner practices or prescribes at full scope.

The path for a new graduate is documentary: the nurse practitioner licence from the board, prescriptive approval under ORS 678.390, a federal DEA registration, and Oregon PDMP registration once the DEA number issues (OAR 851-055-0078(3)).

A clinician relocating to Oregon finds nothing in these sources that defers authority behind years practiced in the state.

What Oregon does police is the title: ORS 678.375(2) makes it unlawful to practice as a nurse practitioner, hold oneself out to the public or an employer, or use the initials, name, title, designation or abbreviation until and unless the board licence is in hand.

No collaborative or supervisory agreement appears in the sources read: no physician signature, no APRN-per-physician ratio, no meeting frequency, no chart-review percentage, and nothing filed with a medical board.

Consultation and collaboration do appear in the scope rule, but not as a gate: (5)(g) lists them among the things the NP's independent practice may include, and (7) puts the NP under a duty to recognize the limits of their knowledge and experience and to resolve situations beyond that expertise by consulting with or referring clients to other health care providers — a duty the NP owes the client, naming no physician and no agreement.

What stands in an agreement's place is board discipline: ORS 678.390(7) lets the board deny, suspend or revoke the prescription-writing authority upon proof that it has been abused, through a contested case under ORS chapter 183, and discipline the licensee under ORS 678.111.

ORS 678.390(1) reaches controlled substances in schedules II through V, and no Schedule II day-supply cap, setting restriction or physician sign-off appears in the nursing statute or board rules read; ORS 678.375(4) makes scope the limit: drugs must be included within the NP's scope of practice as defined by board rules — a PMHNP's outpatient ADHD stimulant prescribing sits within it.

Board rule ties prescribing to the DEA certificate level (851-055-0078(5)(a)) and requires APRNs with a DEA number to register with the Oregon Prescription Drug Monitoring Program (851-055-0078(3)); 0078(1) folds in state law including ORS 430 and 475 and OAR 415 and 855, not read for this page.

Before the initial controlled-substance prescription and at intervals the prescriber sets based on the client's response, the APRN must hold and document a complete discussion with the client or the person authorized to make health care decisions for the client — diagnosis, risks, benefits, alternatives, side effects, addiction and withdrawal potential — with a plan for periodic review (851-055-0078(5)(b)).

A separate state controlled-substance registration was not located in the sources read.

The board's scope rule is broad: assessment, diagnosis, counseling, admission of clients to hospitals and health services including home health, hospice and drug and alcohol treatment, and the prescribing, dispensing and administration item quoted below (OAR 851-055-0020(5)) — always within the scope the NP is educationally prepared for and has maintained competency in (851-055-0020(8)).

Dispensing is a separate application to the board under ORS 678.390(2), with pharmacy-grade labeling, record keeping and inspection rules attached (ORS 678.390(5)).

Federally, the PMHNP registers with the DEA as a mid-level practitioner (21 CFR 1300.01) — a registration that covers only what Oregon allows — and the DEA/HHS telemedicine flexibilities, extended through December 31, 2026 (90 FR 61301), remove the federal in-person evaluation requirement without altering these state rules.

Oregon has not enacted the APRN Compact.

The compact takes effect only once seven states enact it, and as of September 2026 five had (Delaware, North Dakota, South Dakota, Utah and Wyoming), so no APRN holds a multistate APRN licence today.

The Nurse Licensure Compact is an RN compact and gives no nurse practitioner authority in another state.

To practice as a PMHNP in Oregon you need the Oregon nurse practitioner licence and prescriptive approval from the Board of Nursing.

The 2025-edition ORS chapter 678 page carries a note that sections were amended or repealed during the 2026 regular session and that new sections were enacted (2026 Session Laws ch. 0109 among them) — which sections those are was not checked in the sources read, so confirm current text with the board or the legislature before relying on it.

ORS 678.375 was last amended by 2021 c.189.

On the rule side, the old nurse practitioner divisions 851-050 and 851-056 are repealed and their content now lives in division 55; the scope rule's latest amendment in the sources read took effect October 1, 2023.